Ataxia-pancytopenia syndrome

From WikiMD's WELLNESSPEDIA

(Redirected from Myelocerebellar disorder)


Ataxia-pancytopenia syndrome
Synonyms Ataxia-pancytopenia syndrome
Pronounce N/A
Specialty N/A
Symptoms Ataxia, Pancytopenia, Cerebellar ataxia
Complications Infections, Bleeding disorders
Onset Childhood
Duration Chronic
Types N/A
Causes Genetic mutation
Risks Family history
Diagnosis Genetic testing, Blood test, Bone marrow biopsy
Differential diagnosis Ataxia-telangiectasia, Fanconi anemia
Prevention N/A
Treatment Supportive care, Blood transfusion, Bone marrow transplant
Medication N/A
Prognosis Variable
Frequency Rare
Deaths N/A


Ataxia-pancytopenia syndrome is a rare, genetic, neurological disorder characterized by early-onset cerebellar ataxia, associated with hematological abnormalities, including pancytopenia and myelodysplastic syndrome, and a predisposition to developing myeloid leukemia.

Symptoms[edit]

The symptoms of Ataxia-pancytopenia syndrome include:

Causes[edit]

Ataxia-pancytopenia syndrome is caused by mutations in the SAMD9L gene. This gene provides instructions for making a protein that is involved in controlling cell growth and division.

Diagnosis[edit]

Diagnosis of Ataxia-pancytopenia syndrome is based on the presence of characteristic signs and symptoms. Genetic testing can confirm the diagnosis.

Treatment[edit]

Treatment of Ataxia-pancytopenia syndrome is focused on managing the symptoms. This may include physical therapy for ataxia and treatment for hematological abnormalities.

Prognosis[edit]

The prognosis for individuals with Ataxia-pancytopenia syndrome varies. Some individuals may have a normal lifespan, while others may have a shortened lifespan due to complications of the disorder.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.